Perguntar
Consultar
Descobrir
Calcular
Cadastre-se
Cadastre-se
Entrar
Entrar
Descobrir
Upfront mFOLFOXIRI/panitumumab improved overall survival vs mFOLFOX/panitumumab in RAS/BRAF wild-type metastatic colorectal cancer (TRIPLETE, 5-year results) - Notícias Vera Health